Clinical trial
Prospective, Non-interventional Study to Evaluate the Efficacy and Safety of NOVOCART Inject for the Treatment of Cartilage Defects in the Knee in Pediatric Patients With Closed Epiphyses
NCT05391841 is registered in ClinicalTrials.gov with Tetec AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Non-interventional Study to Evaluate the Efficacy and Safety of NOVOCART Inject for the Treatment of Cartilage Defects in the Knee in Pediatric Patients With Closed Epiphyses
- Lead sponsor
- Tetec AG
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- May 31, 2025
- Completion date
- May 31, 2032
- Enrollment
- 0 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
cartilage disease